IN-SILICO ANALYSIS OF PHYTOCOMPOUNDS FOR INHIBITION OF NICOTINE ACETYL- COA RECEPTOR (NACHR) MEDIATED LUNG CANCER
Keywords:
Anti-cancer activity, Docking, Ligands, Lung cancer, Nicotine Acetyl-CoA receptor (nAChR) and TubulinAbstract
Objective: Lung cancer is mostly found in cigarette smokers. Nicotine Acetyl-CoA receptor (nAChR) is found to be responsible for this cancerous activity. When cigarette containing nicotine binds with this receptor of lung cells the carcinogenic activity is initiated. Hence, there is a possibility for the prevention of lung cancer formation when the nicotine is competitively inhibited by an interfering molecule preferably from natural products. This will add additional support in the management of lung cancer. This study was planned to identify the natural compounds which have more affinity to the nicotine Acetyl-CoA receptor (nAChR) than the nicotine by in silico evaluation using Auto dock software.
Methods: About six compounds were subjected and proved with preclinical studies were obtained from a literature survey and were computed for docking and characterization.
Results: Results showed that Taxol had minimum energy level of -11.54 kcal/mol to the nicotine Acetyl-CoA receptor (nAChR) compared to the nicotine energy level of -7.01. Other molecules are having the activity in the following order Combretastatins < Camptothecin < Liriodenine < Curcumin and Podophyllotoxin < Taxol.
Conclusion: It is concluded that these data may be useful for the preparation of different combinations and formulations for the management of lung cancer.
Â
Downloads
References
Chia HL, Chih HW, Yuan SH. From smoking to cancers: targets to neuronal nicotinic acetylcholine receptors. J Oncol 2011;1:1-10.
Eliot RS. Muscarinic receptor agonists and antagonists: effects on cancer. Handb Exp Pharmacol 2012;208:451–68.
Srivastava V, Negi AS, Kumar JK, Gupta MM, Khanuja SP. Plant-based anticancer molecules: a chemical and biological profile of some important leads. Bioorg Med Chem 2005;13:5892–908.
Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, Bhatt ID, et al. From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin Ther Targets 2006;1:87-118.
Celie PH, Van SE, Van WJ, Brejc K, Smit AB, Sixma TK. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in achbp crystal structures. Neuron 2004;41:907-14.
Cenciarelli C, Tanzarella C, Vitale I, Pisano C, Crateri P, Meschini S, et al. The tubulin-depolymerising agent combretastatin-4 induces ectopic aster assembly and mitotic catastrophe in lung cancer cells. Apoptosis 2008;13:659-69.
Li QY, Zu YG, Sh RZ, Yao LP. Review camptothecin: current perspectives. Curr Med Chem 2008;13:2021-39.
Zhen FC, Hong L, Yan CL. Traditional chinese medicine active ingredient-metal based anticancer agents. Recent Adv Theor Practice Chin Med 2012:427-52.
Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: An‘‘old-age†disease with an ‘‘age-old†solution. Cancer Lett 2008;267:133–64.
Murielle M, Surinder KB. Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chin Med 2011;31:1-19.
Ying QL, Liu Y, Xuan T. Podophyllotoxin: Current perspectives. Curr Bioact Compd 2007;3:37-66.
Chia HY, Susan BH. Taxol mediates serine phosphorylation of the 66-kda shc isoform. Am Assoc Cancer Res 2000;60:5171-8.
Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, et al. The antitumor activities of flavonoids. In vivo 2005;5:895-909.
Gordon MC, David JN. Plants as a source of anti-cancer agents. J Ethnopharmacol 2005;100:72–9.
Egleton RD, Brown KC, Dasgupta P. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci 2008;3:151-8.
Vineshkumar T, Puliyappadamba, Vino TC, Arun KT, Thulasidasan, Smitha VB, et al. Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent. Mol Cancer 2010;9:220.
Campain JA. Toxicological highlight nicotine: potentially a multifunctional carcinogen. Toxicol Sci 2004;79:1–3.
Pingfang S, Harmanjatinder SS, Xiao WF. Activated cholinergic signaling provides a target in squamous cell lung carcinoma. Cancer Res 2008;68:4693-4700.
Baskaran C, Ramachandran M. Computational molecular docking studies on Anti cancer drugs. Asian Pac J Trop Dis 2012:734-8.
Joyce NM, Samundeeswari A, Deepa SP. Natural plant resources in anti-cancer therapy-A review. Res Plant Biol 2011;3:01-14.
Mohammed N, Iddya K, Indrani K. In silico identification and characterization of novel drug targets and outer membrane proteins in the fish pathogen Edwardsiella tarda. Open Access Bioinf 2011;3:37-42.